“Chronic fatigue” is a description, not a single diagnosis. It covers several distinct situations that need different handling. The first is myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a defined condition whose core feature is post-exertional malaise: symptoms that flare, sometimes for days, after activity that used to be routine. Unrefreshing sleep, cognitive difficulty and autonomic symptoms sit alongside it.¹ Most people with ME/CFS wait a long time for a diagnosis, and pacing rather than pushing is the safest starting point.¹

The second situation is persistent fatigue that is genuinely multifactorial: no single disease, but several smaller drivers stacking up. The third is post-viral fatigue. Since 2020 this has become far more common, and a large share of people with long COVID report severe, lasting fatigue.³ In one post-COVID cohort, over half met an established ME/CFS case definition, which tells you how much these categories overlap.²

The reason this matters when choosing a clinic is simple: the three situations need different approaches, and a clinic that treats every tired patient the same way will get some of them wrong. The first thing to look for is whether the clinic distinguishes them at all.

Many people arrive at a fatigue clinic having already been told their blood tests are normal. Usually that is accurate as far as it goes. The problem is that a standard fatigue screen is narrow, and the drivers of fatigue are spread across systems that a short panel does not reach.

Iron is the clearest example. Fatigue can arrive well before anaemia does. Ferritin can be low while haemoglobin is still comfortably inside range, so a report that only flags anaemia can miss it entirely. In randomised trials, iron supplementation reduced self-reported fatigue in non-anaemic, iron-deficient adults, even though it did little for objective exercise capacity.⁴ A separate meta-analysis reached the same conclusion: improving iron status can lower fatigue in people who were never anaemic.⁵ That signal is invisible if ferritin is not measured, or if a low-but-in-range ferritin is waved through.

The same logic applies to the thyroid, to B12 and folate, to inflammation, and to blood sugar regulation. Each can contribute to fatigue while sitting inside a reference range built to detect disease rather than measure function. A clinic that stops at “your bloods are normal” has answered a narrower question than the one you came in with.

The value of a dedicated fatigue clinic is the breadth and depth of the questions it asks. A thorough assessment starts with a proper history (onset, pattern through the day, what makes it worse, whether an infection preceded it), and then tests the systems that history points to.

The thyroid deserves more than a lone TSH. Free T3, free T4, reverse T3 and thyroid antibodies together give a fuller picture, and subclinical hypothyroidism can present with fatigue and low mood while TSH is only mildly raised.⁶ The HPA axis is the other system standard screens skip. Total cortisol on a single morning blood draw cannot show the daily rhythm, and the research in chronic fatigue points to a flattened, blunted curve rather than a single abnormal value.⁷ Mild hypocortisolism and an attenuated daily variation are among the more consistent findings.⁸ Reading that pattern needs a multi-point cortisol curve, not one timestamp.

Iron studies with ferritin, B12 and folate, metabolic markers such as fasting insulin and HbA1c, inflammatory markers, and a look at sleep quality round out the picture. Nutrient status is worth measuring rather than guessing at: the response to something as simple as vitamin D varies widely between individuals, so a flat assumption about dose or need is unreliable.⁹ The point of the breadth is not to test everything for its own sake. It is to find which of these systems is actually carrying the load, using functional ranges that ask whether a marker is where it works best, not merely where disease begins.

Breadth of testing is only half of what makes a clinic worth choosing. The other half is what happens to the results. A baseline is a starting point, not a verdict. Once the drivers are identified, the work is a considered plan aimed at the ones actually carrying the load, followed by a retest that confirms whether they moved.

Different systems move at different speeds, and a good clinic sets expectations accordingly. Fast markers such as iron, thyroid and inflammation can shift within roughly eight to twelve weeks. The HPA axis is slower and often takes six to nine months to re-slope. Retesting at sensible intervals is what separates real change from a good week. Cumulative subjective improvement is easy to dismiss; an objective change measured against a baseline is not. This is the same logic that underpins a structured approach to recovery from burnout, where the retest is where the plan proves itself.

So the shortlist is short. A clinic worth choosing distinguishes the different kinds of fatigue, investigates across systems rather than one panel, interprets against functional ranges, and measures change over time instead of asking you to report it. In Australia much of this can run by telehealth, with local pathology collection, so a thorough assessment does not depend on living near a capital city.